Digital Therapeutics Market Professional and In-Depth Analysis by 2027

1. Digital Therapeutics Market Publication Month:  Aug 2018| No. of Pages: 150 | Report Code: TIPHE100000856   | Category: Medical Device Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application (Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, Others); Distribution Channel (Patients, Providers, Payers, and Employers) and Geography E-Mail : sales@theinsightpartners.com

2. Digital Therapeutics Market Publication Month:  Aug 2018| No. of Pages: 150 | Report Code: TIPHE100000856   | Category: Medical Device Introduction: According to a new market research study titled ‘Digital Therapeutics Market to 2025 – Global Analysis and Forecasts by Application and Distribution Channel, the global digital therapeutics market was valued at US$ 1,993.2 Mn in 2017 and is estimated to reach US$ 8,941.1 Mn by 2025. The market is estimated to grow with a CAGR of 20.8% from 2018-2025.The report highlights the trends prevalent in the global digital therapeutics market and the factors driving the market along with those that act as deterrents to its growth. Global digital therapeutics market, based on the application is segmented into diabetes, cardiovascular disease, central nervous system disease, respiratory diseases, smoking cessation, musculoskeletal disease and others. In 2017, diabetes segment held the largest share, by application. The segment is also anticipated to grow at a significant rate during the forecast period, since there has been an increase in the incidence of diabetes across the globe. E-Mail : sales@theinsightpartners.com

3. Digital Therapeutics Market Publication Month:  Aug 2018| No. of Pages: 150 | Report Code: TIPHE100000856   | Category: Medical Device Global digital therapeutics market is expected to grow in the coming years, owing to the rising pressure on healthcare providers to reduce healthcare cost in the market. The fiscal pressure and patent cliffs compel healthcare providers to cut on drug prices, encourage the use of generics and scale back the reimbursement. This in turn is gradually reducing the profit margins and annual net sales of the healthcare companies that leads to immediate requirement of a strategic plan so as to cut down on the operational costs. The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global Digital Therapeutics market based on products, application, and end users. It also provides market size and forecast till 2025 for overall Digital Therapeutics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region. The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. E-Mail : sales@theinsightpartners.com

4. Digital Therapeutics Market Publication Month:  Aug 2018| No. of Pages: 150 | Report Code: TIPHE100000856   | Category: Medical Device Strategic Insights Product launch/update and partnerships were observed as the most adopted strategy in global digital therapeutics industry. Few of the product approvals and partnerships made by the players in the market are listed below: 2017: In November, Propeller Health and Express Scripts entered into a partnership to provide Propeller’s FDA-cleared digital solutions to Express Scripts to manage asthma or COPD. 2016: In November, Propeller Health received FDA approval for its Propeller platform for use with GSK’s Ellipta inhaler. 2018: In April, Canary Health entered into a partnership with NMRHCA to offer the Better Choices, Better Health (BCBH) digital therapeutics program in New Mexico. 2016: In June, Canary Health partnered with Medtronic to expand their diabetes care offerings with Canary Health's self-management suite for pre-diabetes, diabetes and related comorbidities. Get a PDF Sample copy of Digital Therapeutics Market: https://www.theinsightpartners.com/sample/TIPHC00002236 E-Mail : sales@theinsightpartners.com

5. Digital Therapeutics Market Publication Month:  Aug 2018| No. of Pages: 150 | Report Code: TIPHE100000856   | Category: Medical Device • The List of Companies • Propeller Health • CANARY HEALTH • Noom, Inc. • 2Morrow Inc. • Livongo Health • Proteus Digital Health • WellDoc, Inc. • Fitbit, Inc. • Omada Health, Inc. • MANGO HEALTH • Inquire more @ https://www.theinsightpartners.com/inquiry/TIPHC00002236 E-Mail : sales@theinsightpartners.com